BioWorld

Jan. 3, 2007

View Archived Issues

UK Firm Spirogen Focuses On DNA-Targeted Therapies

Nearly three years after moving its first agent into Phase I trials, Spirogen Ltd. is starting off 2007 with similar plans for a second compound. (BioWorld Today) Read More

Biomira Launches Clinical Trials Of Cancer-Fighting Therapies

Read More

New Studies Show How Host, Gut Guests And Weight Relate

Read More

New Breast Cancer Gene Moves Focus To Role Of DNA Repair

Read More

Other News To Note

Read More